Matthew Harrison
Stock Analyst at Morgan Stanley
(3.51)
# 884
Out of 5,058 analysts
706
Total ratings
49.18%
Success rate
4.2%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHVS Pharvaris | Maintains: Overweight | $34 → $37 | $24.54 | +50.77% | 15 | Nov 14, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Maintains: Equal-Weight | $8 → $4 | $1.33 | +200.75% | 5 | Nov 12, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Overweight | $104 → $98 | $52.56 | +86.45% | 23 | Oct 28, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $144 → $149 | $167.93 | -11.27% | 55 | Oct 10, 2025 | |
| MRNA Moderna | Maintains: Equal-Weight | $31 → $32 | $24.18 | +32.34% | 26 | Oct 10, 2025 | |
| REGN Regeneron Pharmaceuticals | Maintains: Overweight | $761 → $756 | $702.75 | +7.58% | 56 | Oct 10, 2025 | |
| ARGX argenx SE | Maintains: Overweight | $766 → $1,040 | $914.59 | +13.71% | 26 | Oct 1, 2025 | |
| DNLI Denali Therapeutics | Maintains: Overweight | $33 → $30 | $16.92 | +77.30% | 13 | Aug 18, 2025 | |
| INSM Insmed | Downgrades: Equal-Weight | $112 → $126 | $203.56 | -38.10% | 19 | Aug 13, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $81 → $83 | $28.00 | +196.43% | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $4 | $0.75 | +432.20% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $460 → $439 | $421.03 | +4.27% | 41 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $20 | $16.39 | +22.03% | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Positive | $215 | $166.65 | +29.01% | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $130 → $135 | $128.07 | +5.41% | 42 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6.2 → $6 | $3.15 | +90.48% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $5 | $1.19 | +320.17% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $178 | $130.00 | +36.92% | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $28.16 | +98.86% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $26.87 | +104.69% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $1.22 | +145.90% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $28.00 | -60.71% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $2.52 | +177.78% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $30.57 | +4.68% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $3.72 | +410.75% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $2.50 | -60.00% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $21.27 | -52.99% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $11.51 | -30.50% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $30.49 | +44.31% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $3.40 | +282.35% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $80 | $17.22 | +364.58% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $60 | $4.68 | +1,182.05% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $101.43 | +112.95% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $4.02 | +24.38% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $1.81 | +176.24% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $232.91 | -21.86% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $19.53 | -53.92% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $54.34 | -26.39% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $342.40 | -17.64% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $460.76 | -54.42% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $24.88 | +109.00% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $202.51 | -14.57% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $31.86 | +276.65% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $9.46 | +1,464.48% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $95.05 | -13.73% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $45.79 | +44.14% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $4.01 | +872.57% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $38.65 | +19.02% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $7.45 | +369.80% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $1,049.60 | -73.80% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.80 | +578.57% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $10.93 | +467.25% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $15.38 | +12.16% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $101.32 | -18.08% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $64.79 | -84.57% | 4 | Sep 10, 2018 |
Pharvaris
Nov 14, 2025
Maintains: Overweight
Price Target: $34 → $37
Current: $24.54
Upside: +50.77%
Zentalis Pharmaceuticals
Nov 12, 2025
Maintains: Equal-Weight
Price Target: $8 → $4
Current: $1.33
Upside: +200.75%
BioMarin Pharmaceutical
Oct 28, 2025
Maintains: Overweight
Price Target: $104 → $98
Current: $52.56
Upside: +86.45%
Biogen
Oct 10, 2025
Maintains: Equal-Weight
Price Target: $144 → $149
Current: $167.93
Upside: -11.27%
Moderna
Oct 10, 2025
Maintains: Equal-Weight
Price Target: $31 → $32
Current: $24.18
Upside: +32.34%
Regeneron Pharmaceuticals
Oct 10, 2025
Maintains: Overweight
Price Target: $761 → $756
Current: $702.75
Upside: +7.58%
argenx SE
Oct 1, 2025
Maintains: Overweight
Price Target: $766 → $1,040
Current: $914.59
Upside: +13.71%
Denali Therapeutics
Aug 18, 2025
Maintains: Overweight
Price Target: $33 → $30
Current: $16.92
Upside: +77.30%
Insmed
Aug 13, 2025
Downgrades: Equal-Weight
Price Target: $112 → $126
Current: $203.56
Upside: -38.10%
Legend Biotech
Aug 12, 2025
Maintains: Overweight
Price Target: $81 → $83
Current: $28.00
Upside: +196.43%
Aug 12, 2025
Maintains: Overweight
Price Target: $6 → $4
Current: $0.75
Upside: +432.20%
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $460 → $439
Current: $421.03
Upside: +4.27%
Jul 29, 2025
Maintains: Equal-Weight
Price Target: $15 → $20
Current: $16.39
Upside: +22.03%
Jul 15, 2025
Initiates: Positive
Price Target: $215
Current: $166.65
Upside: +29.01%
Apr 25, 2025
Maintains: Overweight
Price Target: $130 → $135
Current: $128.07
Upside: +5.41%
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $3.15
Upside: +90.48%
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $1.19
Upside: +320.17%
Feb 21, 2025
Maintains: Buy
Price Target: $160 → $178
Current: $130.00
Upside: +36.92%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $28.16
Upside: +98.86%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $26.87
Upside: +104.69%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $1.22
Upside: +145.90%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $28.00
Upside: -60.71%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $2.52
Upside: +177.78%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $30.57
Upside: +4.68%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $3.72
Upside: +410.75%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $2.50
Upside: -60.00%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $21.27
Upside: -52.99%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $11.51
Upside: -30.50%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $30.49
Upside: +44.31%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $3.40
Upside: +282.35%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $140 → $80
Current: $17.22
Upside: +364.58%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $100 → $60
Current: $4.68
Upside: +1,182.05%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $101.43
Upside: +112.95%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $4.02
Upside: +24.38%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $1.81
Upside: +176.24%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $232.91
Upside: -21.86%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $19.53
Upside: -53.92%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $54.34
Upside: -26.39%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $342.40
Upside: -17.64%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $460.76
Upside: -54.42%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $24.88
Upside: +109.00%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $202.51
Upside: -14.57%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $31.86
Upside: +276.65%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $9.46
Upside: +1,464.48%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $95.05
Upside: -13.73%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $45.79
Upside: +44.14%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $4.01
Upside: +872.57%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $38.65
Upside: +19.02%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $7.45
Upside: +369.80%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $1,049.60
Upside: -73.80%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.80
Upside: +578.57%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $10.93
Upside: +467.25%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $15.38
Upside: +12.16%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $101.32
Upside: -18.08%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $64.79
Upside: -84.57%